Federal Pharma Technologies
Finance & Banking · Lobbying Client
C
Influence Score
46/100
Moderate Influence
$1.0M
Total Lobby Spend
6
Policy Issues
1
Lobbyists
0
Revolving Door
Federal Pharma Technologies reported $1.0 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 6 policy areas, with primary focus on Banking, Financial Institutions, Taxation. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of Energy
US Senate
Federal Trade Commission
Dept of Commerce
US House of Representatives
Federal Communications Commission
Dept of Transportation
Small Business Administration
Dept of Education
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Brownstein Hyatt LLP | GOVBAN | 1 | $43K |
| 2020 Apr-Jun | Akin Gump LLP | TAXAPPBAN | 1 | $51K |
| 2020 Jul-Sep | BGR Group LLP | BAN | 1 | $60K |
| 2020 Oct-Dec | Akin Gump LLP | BAN | 1 | $47K |
| 2021 Jan-Mar | BGR Group LLP | GOVBANAPP | 1 | $74K |
| 2021 Apr-Jun | BGR Group LLP | TAX | 1 | $60K |
| 2021 Jul-Sep | Holland & Knight LLP | FINBANTAX | 1 | $65K |
| 2021 Oct-Dec | Cassidy & Associates LLP | MEDBAN | 1 | $71K |